Antidepressant-related sexual dysfunction - perspectives from neuroimaging

Pharmacology, Biochemistry, and Behavior
Heiko GrafBirgit Abler

Abstract

Sexual dysfunction is not only a common symptom in major depression but also a frequent side-effect of antidepressant medication, mainly of the selective serotonin reuptake-inhibitors (SSRI) that are often prescribed as a first line treatment option. Despite of the increasing incidence and prescription rates, neuronal mechanisms underlying SSRI-related sexual dysfunction are poorly understood and investigations on this topic are scarce. Neuroimaging techniques, mainly functional magnetic resonance imaging (fMRI), provide a feasible approach to investigate these mechanisms since SSRI-related sexual dysfunction is most likely related to central nervous processes. This review summarizes the recent literature regarding the basic clinical findings and imaging correlates of antidepressant-related sexual dysfunction linking brain regions and networks potentially involved to phases and subcomponents of sexual processing and antidepressant action. In particular, fMRI studies on SSRI antidepressants including paroxetine and SNRIs including bupropion are highlighted.

References

Nov 24, 1998·The Journal of Comparative Neurology·D OngürJ L Price
Dec 22, 1999·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·C C ColemanJ A Ascher
Dec 23, 1999·Current Opinion in Neurobiology·J G Pfaus
Mar 4, 2000·Journal of Affective Disorders·S H KennedyR M Bagby
Jun 10, 2000·The Journal of Clinical Psychiatry·A J GelenbergP Delgado
Nov 14, 2000·Archives of General Psychiatry·C M Meston, P F Frohlich
Dec 1, 2000·Human Brain Mapping·J RedoutéJ F Pujol
Jan 11, 2001·Physiology & Behavior·P F Frohlich, C M Meston
Mar 1, 2002·Human Brain Mapping·Sherif KaramaMario Beauregard
Apr 19, 2002·Brain : a Journal of Neurology·Bruce A ArnowScott W Atlas
May 8, 2002·Nature Reviews. Neuroscience·Maurizio Corbetta, Gordon L Shulman
May 10, 2002·The Journal of Clinical Psychiatry·Anita H ClaytonAlan Metz
Sep 24, 2002·The Annals of Pharmacotherapy·Razmic S GregorianZeba M Khan
Nov 1, 2003·Sleep Medicine·Arthur S WaltersUNKNOWN International Restless Legs Syndrome Study Group
Oct 19, 2004·Physiology & Behavior·Elaine M HullSatoru Sato
Feb 12, 2005·The Journal of Clinical Psychiatry·Michael A Posternak, Mark Zimmerman
Apr 14, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cristina M Del-BenIan M Anderson
Jun 11, 2005·World Journal of Urology·Julien AllardLique M Coolen
Jul 22, 2005·Lancet Neurology·Claudia TrenkwalderArthur S Walters
Oct 29, 2005·The Journal of Comparative Neurology·Janniko R Georgiadis, Gert Holstege
Feb 8, 2006·Biological Psychiatry·Catherine J HarmerGuy M Goodwin
Aug 25, 2006·Nature·Mathias PessiglioneChris D Frith
Sep 19, 2006·NeuroImage·Jorge PonsetiHartwig R Siebner
Nov 8, 2006·Archives of General Psychiatry·Matthew J TaylorZubin Bhagwagar
Nov 23, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Helen E FisherLucy L Brown
Dec 26, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·Amee D BairdDavid C Reutens
May 4, 2007·The Journal of Clinical Psychiatry·Judith A DunnAnita H Clayton
Jun 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Nico U F DosenbachSteven E Petersen
Sep 11, 2007·The Journal of Neuropsychiatry and Clinical Neurosciences·Amit AnandMark J Lowe
Nov 9, 2007·Parkinsonism & Related Disorders·Doron Merims, Nir Giladi

❮ Previous
Next ❯

Citations

Dec 11, 2014·Pharmacogenomics·James M Stevenson, Jeffrey R Bishop
Aug 26, 2014·Expert Opinion on Drug Safety·Anita H ClaytonAlexandra Elizabeth Schuck
Jan 21, 2016·Journal of Sex & Marital Therapy·Tillmann H C KrügerManfred Schedlowski
Nov 1, 2015·CNS Drugs·David S BaldwinMagda Nowak
Mar 30, 2016·Journal of Ethnopharmacology·Carolina López-Rubalcava, Erika Estrada-Camarena
Jan 24, 2015·The International Journal of Neuropsychopharmacology·Heiko GrafBirgit Abler
Aug 16, 2016·The Psychiatric Clinics of North America·Anita H ClaytonJennifer G Votta
Oct 12, 2017·American Journal of Men's Health·Louis Wei-Hsi ChenKuo-Yen Chen
Aug 15, 2017·Current Opinion in Psychiatry·Bernardo C Barata
Apr 21, 2018·Endocrine·Silvia GiattiRoberto Cosimo Melcangi
Sep 20, 2018·International Journal of Impotence Research·José Nuno Trovão, Ege Can Serefoglu
Jan 19, 2018·Therapeutic Advances in Psychopharmacology·Pratap R Chokka, Jeffrey R Hankey
May 12, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Casper SchmidtValerie Voon
Jul 30, 2021·Psychoneuroendocrinology·Silvia GiattiRoberto C Melcangi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.